“Mubadala Bayu”, one of the Mubadala Investment companies “Mubadala”, has announced the structure of its executive leadership, in order to support its focus on operating excellence, strategic growth, and the promotion of innovation in the pharmaceutical industries. This announcement comes within the framework of its keenness to support the drug industry, enhance the drug security system, and provide high -quality basic medical drugs and medical devices, to confirm its commitment to accelerate economic diversity in the UAE and build a knowledge -based economy, dependent on innovation and development in various vital fields. The team includes Dr. Essam Mohamed, CEO, and Hamad Al Marzouqi, Vice President of the CEO. A great emotion, executive financial manager, and Khaled Al -Kaf,
source
